These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 23776681)
1. Phosphorylation of the leukemic oncoprotein EVI1 on serine 196 modulates DNA binding, transcriptional repression and transforming ability. White DJ; Unwin RD; Bindels E; Pierce A; Teng HY; Muter J; Greystoke B; Somerville TD; Griffiths J; Lovell S; Somervaille TC; Delwel R; Whetton AD; Meyer S PLoS One; 2013; 8(6):e66510. PubMed ID: 23776681 [TBL] [Abstract][Full Text] [Related]
2. EVI1 phosphorylation at S436 regulates interactions with CtBP1 and DNMT3A and promotes self-renewal. Paredes R; Kelly JR; Geary B; Almarzouq B; Schneider M; Pearson S; Narayanan P; Williamson A; Lovell SC; Wiseman DH; Chadwick JA; Jones NJ; Kustikova O; Schambach A; Garner T; Amaral FMR; Pierce A; Stevens A; Somervaille TCP; Whetton AD; Meyer S Cell Death Dis; 2020 Oct; 11(10):878. PubMed ID: 33082307 [TBL] [Abstract][Full Text] [Related]
3. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator. Soderholm J; Kobayashi H; Mathieu C; Rowley JD; Nucifora G Leukemia; 1997 Mar; 11(3):352-8. PubMed ID: 9067573 [TBL] [Abstract][Full Text] [Related]
4. EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation. Bard-Chapeau EA; Gunaratne J; Kumar P; Chua BQ; Muller J; Bard FA; Blackstock W; Copeland NG; Jenkins NA Proc Natl Acad Sci U S A; 2013 Jul; 110(31):E2885-94. PubMed ID: 23858473 [TBL] [Abstract][Full Text] [Related]
5. Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity. Sayadi A; Jeyakani J; Seet SH; Wei CL; Bourque G; Bard FA; Jenkins NA; Copeland NG; Bard-Chapeau EA Oncogene; 2016 May; 35(18):2311-21. PubMed ID: 26234679 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia. Vázquez I; Maicas M; Cervera J; Agirre X; Marin-Béjar O; Marcotegui N; Vicente C; Lahortiga I; Gomez-Benito M; Carranza C; Valencia A; Brunet S; Lumbreras E; Prosper F; Gómez-Casares MT; Hernández-Rivas JM; Calasanz MJ; Sanz MA; Sierra J; Odero MD Haematologica; 2011 Oct; 96(10):1448-56. PubMed ID: 21750091 [TBL] [Abstract][Full Text] [Related]
7. [The role and regulation of EVI1 in normal hematopoiesis and hematopoietic malignancies]. Masamoto Y Rinsho Ketsueki; 2024; 65(9):954-960. PubMed ID: 39358295 [TBL] [Abstract][Full Text] [Related]
8. EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2. Gómez-Benito M; Conchillo A; García MA; Vázquez I; Maicas M; Vicente C; Cristobal I; Marcotegui N; García-Ortí L; Bandrés E; Calasanz MJ; Alonso MM; Odero MD Br J Cancer; 2010 Oct; 103(8):1292-6. PubMed ID: 20842122 [TBL] [Abstract][Full Text] [Related]
9. Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements. Sitailo S; Sood R; Barton K; Nucifora G Leukemia; 1999 Nov; 13(11):1639-45. PubMed ID: 10557037 [TBL] [Abstract][Full Text] [Related]
11. EVI1 drives leukemogenesis through aberrant ERG activation. Schmoellerl J; Barbosa IAM; Minnich M; Andersch F; Smeenk L; Havermans M; Eder T; Neumann T; Jude J; Fellner M; Ebert A; Steininger M; Delwel R; Grebien F; Zuber J Blood; 2023 Feb; 141(5):453-466. PubMed ID: 36095844 [TBL] [Abstract][Full Text] [Related]
12. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Lugthart S; van Drunen E; van Norden Y; van Hoven A; Erpelinck CA; Valk PJ; Beverloo HB; Löwenberg B; Delwel R Blood; 2008 Apr; 111(8):4329-37. PubMed ID: 18272813 [TBL] [Abstract][Full Text] [Related]
13. Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins. Palmer S; Brouillet JP; Kilbey A; Fulton R; Walker M; Crossley M; Bartholomew C J Biol Chem; 2001 Jul; 276(28):25834-40. PubMed ID: 11328817 [TBL] [Abstract][Full Text] [Related]
14. The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia. Yamakawa N; Kaneda K; Saito Y; Ichihara E; Morishita K PLoS One; 2012; 7(1):e30706. PubMed ID: 22295105 [TBL] [Abstract][Full Text] [Related]
15. Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis. Kataoka K; Kurokawa M Cancer Sci; 2012 Aug; 103(8):1371-7. PubMed ID: 22494115 [TBL] [Abstract][Full Text] [Related]
16. Zinc finger transcription factor ecotropic viral integration site 1 is induced by all-trans retinoic acid (ATRA) and acts as a dual modulator of the ATRA response. Bingemann SC; Konrad TA; Wieser R FEBS J; 2009 Nov; 276(22):6810-22. PubMed ID: 19843176 [TBL] [Abstract][Full Text] [Related]
17. The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid. Steinmetz B; Hackl H; Slabáková E; Schwarzinger I; Smějová M; Spittler A; Arbesu I; Shehata M; Souček K; Wieser R Cell Cycle; 2014; 13(18):2931-43. PubMed ID: 25486480 [TBL] [Abstract][Full Text] [Related]
18. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Russell M; List A; Greenberg P; Woodward S; Glinsmann B; Parganas E; Ihle J; Taetle R Blood; 1994 Aug; 84(4):1243-8. PubMed ID: 8049440 [TBL] [Abstract][Full Text] [Related]
19. EVI1 Interferes with Myeloid Maturation via Transcriptional Repression of Cebpa, via Binding to Two Far Downstream Regulatory Elements. Wilson M; Tsakraklides V; Tran M; Xiao YY; Zhang Y; Perkins AS J Biol Chem; 2016 Jun; 291(26):13591-607. PubMed ID: 27129260 [TBL] [Abstract][Full Text] [Related]
20. Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors. Bard-Chapeau EA; Jeyakani J; Kok CH; Muller J; Chua BQ; Gunaratne J; Batagov A; Jenjaroenpun P; Kuznetsov VA; Wei CL; D'Andrea RJ; Bourque G; Jenkins NA; Copeland NG Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2168-73. PubMed ID: 22308434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]